What Matters Most in Psychedelic-Assisted Psychotherapy?
CLINICAL REFLECTIONS In June, an advisory committee for the US Food and Drug Administration (FDA) recommended rejecting the psychedelic drug, midomafetamine (MDMA), as a potential treatment for posttraumatic stress disorder (PTSD). After reviewing the …